Seres Therapeutics, Inc. (MCRB) is a publicly traded Healthcare sector company. As of July 28, 2026, MCRB trades at $4.81 with a market cap of $48.08M and a P/E ratio of -0.93. MCRB moved -0.62% today. Year to date, MCRB is -67.41%; over the trailing twelve months it is -66.62%. Its 52-week range spans $4.85 to $29.98. Analyst consensus is buy with an average price target of $17.00. Rallies surfaces MCRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for MCRB shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.81 |
| Market Cap | $48.08M |
| P/E Ratio | -0.93 |
| EPS | $-5.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.98 |
| 52-Week Low | $4.85 |
| Volume | 56.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15M |
| Net Income | $-46.90M |
| Gross Margin | 0.00% |
2 analysts cover MCRB: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.00.